Cargando…
The Role of TREM2 in Alzheimer’s Disease and Other Neurological Disorders
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Late-onset AD (LOAD), is the most common form of Alzheimer’s disease, representing about >95% of cases and early-onset AD represents <5% of cases. Several risk factors have been discovered that are associated with AD, with ad...
Autores principales: | Yaghmoor, Faris, Noorsaeed, Ahmed, Alsaggaf, Samar, Aljohani, Waleed, Scholtzova, Henrieta, Boutajangout, Allal, Wisniewski, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317331/ https://www.ncbi.nlm.nih.gov/pubmed/25664220 http://dx.doi.org/10.4172/2161-0460.1000160 |
Ejemplares similares
-
The Innate Immune System in Alzheimer's Disease
por: Boutajangout, Allal, et al.
Publicado: (2013) -
The Cox-2 Inhibitor Meloxicam Ameliorates Neuroinflammation and Depressive Behavior in Adult Mice after Splenectomy
por: Haile, Michael, et al.
Publicado: (2016) -
Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer’s Mouse Model With Tau Pathology
por: Boutajangout, Allal, et al.
Publicado: (2021) -
Amyloid β and Tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation
por: Scholtzova, Henrieta, et al.
Publicado: (2014) -
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
por: Goñi, Fernando, et al.
Publicado: (2018)